MX9301707A - Composicion farmaceutica par inducir inmunosupresion. - Google Patents

Composicion farmaceutica par inducir inmunosupresion.

Info

Publication number
MX9301707A
MX9301707A MX9301707A MX9301707A MX9301707A MX 9301707 A MX9301707 A MX 9301707A MX 9301707 A MX9301707 A MX 9301707A MX 9301707 A MX9301707 A MX 9301707A MX 9301707 A MX9301707 A MX 9301707A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
induce immunosuppression
rejection
immunosuppression
induce
Prior art date
Application number
MX9301707A
Other languages
English (en)
Inventor
Suren Nath Sehgal
Jay Joseph Armstrong
Chee Ping Eng
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of MX9301707A publication Critical patent/MX9301707A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Esta invención proporciona un método para inducir inmusupresión en un mamífero en necesidad del mismo, el cual comprende administrar una cantidad efectiva anti-rechazo de 29-desmetoxirapamicina solo o junto con uno o más agentes quimioterapéuticos anti-rechazo.
MX9301707A 1992-03-27 1993-03-26 Composicion farmaceutica par inducir inmunosupresion. MX9301707A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85892392A 1992-03-27 1992-03-27

Publications (1)

Publication Number Publication Date
MX9301707A true MX9301707A (es) 1993-09-01

Family

ID=25329511

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9301707A MX9301707A (es) 1992-03-27 1993-03-26 Composicion farmaceutica par inducir inmunosupresion.

Country Status (9)

Country Link
EP (1) EP0562853B1 (es)
JP (1) JP3179235B2 (es)
AT (1) ATE138807T1 (es)
CA (1) CA2092729A1 (es)
DE (1) DE69302945T2 (es)
DK (1) DK0562853T3 (es)
ES (1) ES2089723T3 (es)
GR (1) GR3020310T3 (es)
MX (1) MX9301707A (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2175215C (en) * 1993-11-19 2008-06-03 Yat Sun Or Semisynthetic analogs of rapamycin (macrolides) being immunomodulators
US5527907A (en) * 1993-11-19 1996-06-18 Abbott Laboratories Macrolide immunomodulators
EP1208847B8 (en) 1996-07-30 2007-02-14 Novartis AG Pharmaceutical compositions for the treatment of transplant rejection, as well as autoimmune or inflammatory conditions
EP1143993A4 (en) * 1999-01-22 2004-11-17 Fujisawa Pharmaceutical Co METHOD FOR SUPPRESSING A CONTINUOUS ACUTE ALLOGRAFT REPELLATION
US20100004738A1 (en) * 2005-04-29 2010-01-07 Atrium Medical Corporation Drug delivery coating for use with a medical device and methods of treating vascular injury
US9428845B1 (en) 2010-12-28 2016-08-30 Warp Drive Bio, Inc. Identifying new therapeutic agents
EP3247378B8 (en) 2015-01-09 2023-08-23 Revolution Medicines, Inc. Macrocyclic compounds that participate in cooperative binding and medical uses thereof
TW201629069A (zh) 2015-01-09 2016-08-16 霍普驅動生物科技股份有限公司 參與協同結合之化合物及其用途
CA3000822A1 (en) 2015-10-01 2017-04-06 Warp Drive Bio, Inc. Methods and reagents for analyzing protein-protein interfaces
EP3442599B1 (en) 2016-04-12 2022-03-30 Warp Drive Bio, Inc. Compositions and methods for the production of compounds
CA3042231A1 (en) 2016-10-28 2018-05-03 Ginkgo Bioworks, Inc. Compositions and methods for the production of compounds
KR20220109407A (ko) 2019-11-04 2022-08-04 레볼루션 메디슨즈, 인크. Ras 억제제
WO2021091967A1 (en) 2019-11-04 2021-05-14 Revolution Medicines, Inc. Ras inhibitors
AU2020379734A1 (en) 2019-11-04 2022-05-05 Revolution Medicines, Inc. Ras inhibitors
US11690915B2 (en) 2020-09-15 2023-07-04 Revolution Medicines, Inc. Ras inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA737247B (en) 1972-09-29 1975-04-30 Ayerst Mckenna & Harrison Rapamycin and process of preparation
US4375464A (en) 1981-11-19 1983-03-01 Ayerst, Mckenna & Harrison Inc. Antibiotic AY24,668 and process of preparation
US4894366A (en) 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
US5100899A (en) 1989-06-06 1992-03-31 Roy Calne Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
US5023262A (en) * 1990-08-14 1991-06-11 American Home Products Corporation Hydrogenated rapamycin derivatives
GB9103430D0 (en) * 1991-02-19 1991-04-03 Smithkline Beecham Plc Novel compound
US5080899A (en) 1991-02-22 1992-01-14 American Home Products Corporation Method of treating pulmonary inflammation
US5078999A (en) 1991-02-22 1992-01-07 American Home Products Corporation Method of treating systemic lupus erythematosus
US5091389A (en) 1991-04-23 1992-02-25 Merck & Co., Inc. Lipophilic macrolide useful as an immunosuppressant

Also Published As

Publication number Publication date
DE69302945T2 (de) 1996-10-10
DE69302945D1 (de) 1996-07-11
JPH0616674A (ja) 1994-01-25
GR3020310T3 (en) 1996-09-30
EP0562853B1 (en) 1996-06-05
DK0562853T3 (da) 1996-07-01
ES2089723T3 (es) 1996-10-01
ATE138807T1 (de) 1996-06-15
CA2092729A1 (en) 1993-09-28
JP3179235B2 (ja) 2001-06-25
EP0562853A1 (en) 1993-09-29

Similar Documents

Publication Publication Date Title
MX9301707A (es) Composicion farmaceutica par inducir inmunosupresion.
FI904851A0 (fi) Radiomaerkta antikoagulantpeptider.
DK0565078T3 (da) Hærdelig sammensætning
DE69401335D1 (de) Gleiskettenspannvorrichtung
DE3852436D1 (de) Lichtbogenlöschvorrichtung.
ES2080736T3 (es) Uso de 2,3,4,5-tetrahidro-1h-3-benzazepinas en el tratamiento de trastornos neurologicos.
DE3686022D1 (de) Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
ES2053109T3 (es) Composicion farmaceutica de calcitonina estabilizada.
NO955297D0 (no) Kupong for spill
FI904852A0 (fi) Antikoagulantpeptider.
DK614489D0 (da) Peptidderivater
IT8520234A0 (it) Composizione farmaceutiche adattivita' dopominergica.
IT9004917V0 (it) Accenditore per fluorescenti
FR2692160B1 (fr) Billard polyvalent.
FI934360A0 (fi) Synergistiska antimalariakompositioner innehaollande benflumetol
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
IT8220251A0 (it) Composizione farmaceutica adattivita' immunomodulatrice.
ES536881A0 (es) Mejoras introducidas en el objeto de la patente de invencion n. 516325.
DK1260222T3 (da) Farmaceutiske præparater indeholdende hidtil ukendte iso-butenyl-substituerede taxaner
IT8222224A0 (it) Composizione farmaceutica adattivita' antiartritica.
IT8222225A0 (it) Composizione farmaceutica adattivita' antiulcera.
IT8719949A0 (it) Composizioni farmaceutiche adattivita' immunomodulante.
MX9203089A (es) Composicion para el tratamiento de esquisofrenia.
MX9203709A (es) Composicion citotoxica sinergistica.
ITMI922581A1 (it) Composizione farmaceutica

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status

Owner name: CARDINAL CG COMPANY

MM Annulment or lapse due to non-payment of fees